March 12 (Reuters) - Enodia Therapeutics:
ENODIA THERAPEUTICS STRENGTHENS SEC61 PORTFOLIO THROUGH ACQUISITION OF PRECLINICAL ASSETS FROM KEZAR LIFE SCIENCES
ENODIA THERAPEUTICS - KEZAR TO RECEIVE $1 MILLION UPFRONT AND UP TO $127 MILLION IN MILESTONE PAYMENTS